Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (31-40 of 269) with videos related to

Pageof 27
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 20, 2017
Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical ImprovementSonya L Heltshe, Steven M Rowe, Michelle Skalland, et al.
International Journal of Caring Sciences|November 9, 2020
Gaming Console Home-Based Exercise for Adults with Cystic Fibrosis: Study ProtocolJohn D Lowman, George M Solomon, Steven M Rowe, et al.
Annals of the American Thoracic Society|April 27, 2016
Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic BronchitisGeorge M Solomon, S Vamsee Raju, Mark T Dransfield, et al.
Pediatric Pulmonology|June 23, 2015
Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctorsGeorge M Solomon, Susan G Marshall, Bonnie W Ramsey, et al.
Clinics in Chest Medicine|February 10, 2016
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceS Vamsee Raju, George M Solomon, Mark T Dransfield, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 20, 2020
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airwaysSheylan D Patel, Taylor R Bono, Steven M Rowe, et al.
Chest|March 4, 2015
Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutationShatha Yousef, George M Solomon, Alan Brody, et al.
Plos One|October 24, 2023
An ex vivo rat trachea model reveals abnormal airway physiology and a gland secretion defect in cystic fibrosisElex Harris, Molly Easter, Janna Ren, et al.
Frontiers in Physiology|January 4, 2021
A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated DecayJyoti Sharma, Joseph Abbott, Lauren Klaskala, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2020
Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosisElizabeth Baker, William T Harris, Steven M Rowe, et al.
Pageof 27

Showing results (31-40 of 269) with videos related to

Sort By:
Pageof 27
American Journal of Respiratory and Critical Care Medicine|December 20, 2017
Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical ImprovementSonya L Heltshe, Steven M Rowe, Michelle Skalland, et al.
International Journal of Caring Sciences|November 9, 2020
Gaming Console Home-Based Exercise for Adults with Cystic Fibrosis: Study ProtocolJohn D Lowman, George M Solomon, Steven M Rowe, et al.
Annals of the American Thoracic Society|April 27, 2016
Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic BronchitisGeorge M Solomon, S Vamsee Raju, Mark T Dransfield, et al.
Pediatric Pulmonology|June 23, 2015
Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctorsGeorge M Solomon, Susan G Marshall, Bonnie W Ramsey, et al.
Clinics in Chest Medicine|February 10, 2016
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceS Vamsee Raju, George M Solomon, Mark T Dransfield, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 20, 2020
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airwaysSheylan D Patel, Taylor R Bono, Steven M Rowe, et al.
Chest|March 4, 2015
Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutationShatha Yousef, George M Solomon, Alan Brody, et al.
Plos One|October 24, 2023
An ex vivo rat trachea model reveals abnormal airway physiology and a gland secretion defect in cystic fibrosisElex Harris, Molly Easter, Janna Ren, et al.
Frontiers in Physiology|January 4, 2021
A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated DecayJyoti Sharma, Joseph Abbott, Lauren Klaskala, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2020
Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosisElizabeth Baker, William T Harris, Steven M Rowe, et al.
Pageof 27